BMI View: We maintain a positive outlook for Malaysia's pharmaceutical and healthcare market. The
evolution of the country's medical tourism sector will see the agglomeration of private healthcare providers
along key geographic hubs. Government efforts to develop Joho ..."
BMI View: After years of rapid expansion, the outlook for Malaysia's pharmaceutical market is very
positive, with medicine demand being driven by a growing population and rising disease burden We expect
the government's commitment to the improvement of healthcare serv ..."
BMI View: We hold a bullish outlook for Malaysia's pharmaceutical market over our forecast period. We
believe the government's commitment to expanding healthcare access coupled with the country's growing
population and disease burden will drive medicine demand in the ..."
BMI View: Although the 2016 health budget assigned to the ministry of health comes in lower than in 2015,
we believe the government remains committed to expanding healthcare access. The construction of more
health clinics under the 1Malaysia brand and the increased nu ..."
Overview of the health supplement market in Malaysia
The research analyst predicts the health supplement market in Malaysia to grow at a CAGR of 7% during the forecast period. The rise in the aging population in Malaysia is the key driver for the marke ..."
BMI View: Malaysia's epidemiological profile will remain attractive to pharmaceutical companies as the
country sees a rising burden of both communicable and non-communicable diseases. This commercial
opportunity is further reinforced by the government's commitment to ..."
BMI View: Despite the decline in oil prices impacting government spending, we believe the Malaysian
government will be able to maintain its commitment to the country's healthcare sector as it continues
diversification of its revenue base. Moreover, healthcare provisio ..."
BMI View: Commercial opportunities for private healthcare providers in Malaysia will be buoyed by the
robust growth in the country's medical tourism industry. Driven by strong demand from Asia and the
weakening currency, we highlight that this trend will also create r ..."
BMI View: Malaysia's 2015 budget reinforces our upbeat outlook on the country's pharmaceutical market.
Rising healthcare expenditure plans to improve medical access and efforts to mitigate the impact of the
Goods and Service Tax on medicine prices will provide compani ..."
BMI View: We remain generally optimistic towards Malaysia's commitment to provide better quality and
access to healthcare, as the government plans to expand and upgrade its hospital network. However, we
have downgraded Malaysia's pharmaceutical sales forecast due to a ..."